Flies as the ointment: Drosophila modeling to enhance drug discovery
暂无分享,去创建一个
Aaron J. Bell | T. C. Dockendorff | S. McBride | Thomas C Dockendorff | Aaron J Bell | Sean M J McBride | S. Mcbride | Sean M J Mcbride
[1] P. Davies,et al. Characterization of Pathology in Transgenic Mice Over-Expressing Human Genomic and cDNA Tau Transgenes , 2000, Neurobiology of Disease.
[2] E M Wijsman,et al. A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.
[3] M. Konsolaki,et al. A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster , 2004, Molecular and Cellular Neuroscience.
[4] Ronald W. Davis,et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.
[5] M. Diamond,et al. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. , 2007, Human molecular genetics.
[6] M. Fortini,et al. Analysis of dominant enhancers and suppressors of activated Notch in Drosophila. , 1996, Genetics.
[7] S. Bryson,et al. Review of recent epidemiological studies of mental retardation: prevalence, associated disorders, and etiology. , 1987, American journal of mental retardation : AJMR.
[8] Tian Xu,et al. A Genetic Screen in Drosophila for Metastatic Behavior , 2003, Science.
[9] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[10] M. Fortini,et al. The suppressor of hairless protein participates in notch receptor signaling , 1994, Cell.
[11] G. Rubin,et al. Targeted mutagenesis by homologous recombination in D. melanogaster. , 2002, Genes & development.
[12] R. Bourtchouladze,et al. Targeting the CREB pathway for memory enhancers , 2003, Nature Reviews Drug Discovery.
[13] B. de Strooper,et al. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. , 2003, Neuron.
[14] Dominic M. Walsh,et al. Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.
[15] B. Dickson. Wired for Sex: The Neurobiology of Drosophila Mating Decisions , 2008, Science.
[16] Daniela C. Zarnescu,et al. Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. , 2008, Nature chemical biology.
[17] Y. Jan,et al. Efficient Ends-Out Gene Targeting In Drosophila , 2008, Genetics.
[18] R. J. Kelleher,et al. The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism , 2007, Proceedings of the National Academy of Sciences.
[19] K. Siwicki,et al. Drosophila Lacking dfmr1 Activity Show Defects in Circadian Output and Fail to Maintain Courtship Interest , 2002, Neuron.
[20] S. Lindquist,et al. The FLP recombinase of yeast catalyzes site-specific recombination in the drosophila genome , 1989, Cell.
[21] Leslie C Griffith,et al. Unconventional sex: fresh approaches to courtship learning , 2004, Current Opinion in Neurobiology.
[22] S. Warren,et al. Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function , 2008, Neuron.
[23] M. Scott,et al. Automated sorting of live transgenic embryos , 2001, Nature Biotechnology.
[24] H. Richardson,et al. Using Drosophila melanogaster to map human cancer pathways , 2005, Nature Reviews Cancer.
[25] John Q. Trojanowski,et al. Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.
[26] Mark F. Bear,et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.
[28] Ann-Shyn Chiang,et al. Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease , 2004 .
[29] P. S. St George-Hyslop,et al. Biology of presenilins as causative molecules for Alzheimer disease , 1999, Clinical genetics.
[30] Ethan Bier,et al. Drosophila, the golden bug, emerges as a tool for human genetics , 2005, Nature Reviews Genetics.
[31] M. Beal,et al. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. , 2005, Current drug targets. CNS and neurological disorders.
[32] Ronald L. Davis,et al. P{Switch}, a system for spatial and temporal control of gene expression in Drosophila melanogaster , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] Francesco Scaravilli,et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.
[34] Christine Klein,et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study , 2008, Human Genetics.
[35] G. Rubin,et al. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase , 1991, Cell.
[36] Ronald L. Davis,et al. Gene expression systems in Drosophila: a synthesis of time and space. , 2004, Trends in genetics : TIG.
[37] L. Ukani,et al. Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. , 2008, Human molecular genetics.
[38] Michael Peyton,et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells , 2007, Nature.
[39] Nancy M Bonini,et al. Drosophila as a model for human neurodegenerative disease. , 2005, Annual review of genetics.
[40] Andrew J. Schroeder,et al. Drosophila Fragile X Protein, DFXR, Regulates Neuronal Morphology and Function in the Brain , 2002, Neuron.
[41] G. Rubin,et al. The BDGP Gene Disruption Project , 2004, Genetics.
[42] W. Hillen,et al. Tetracycline-inducible systems for Drosophila , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[43] Mark F. Bear,et al. Correction of Fragile X Syndrome in Mice , 2007, Neuron.
[44] Leslie Michels Thompson,et al. Drosophila in the Study of Neurodegenerative Disease , 2006, Neuron.
[45] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[46] Ronald L. Davis,et al. Spatiotemporal Rescue of Memory Dysfunction in Drosophila , 2003, Science.
[47] G. Rubin,et al. Analysis of genetic mosaics in developing and adult Drosophila tissues. , 1993, Development.
[48] L. Thompson,et al. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders , 2008, Nature Reviews Drug Discovery.
[49] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[50] R. Nussbaum,et al. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.
[51] D. Housman,et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.
[52] D. Loesch,et al. Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. , 2000, American journal of medical genetics.
[53] Liqun Luo,et al. Mosaic Analysis with a Repressible Cell Marker for Studies of Gene Function in Neuronal Morphogenesis , 1999, Neuron.
[54] M. Fortini,et al. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants , 1999, Nature.
[55] P. Lansbury,et al. The C‐Terminus of the β Protein is Critical in Amyloidogenesis a , 1993 .
[56] Michele P Calos,et al. Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. , 2004, Genetics.
[57] B. Dickson,et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila , 2007, Nature.
[58] R. Greenspan,et al. Courtship in Drosophila. , 2003, Annual review of genetics.
[59] M. Daly,et al. Genetic Mapping in Human Disease , 2008, Science.
[60] U. Wagner,et al. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. , 1996, Journal of cell science.
[61] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[62] P. Lansbury,et al. The C-terminus of the beta protein is critical in amyloidogenesis. , 1993, Annals of the New York Academy of Sciences.
[63] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[64] D. Selkoe,et al. Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.
[65] Lili Wan,et al. Characterization of dFMR1, a Drosophila melanogaster Homolog of the Fragile X Mental Retardation Protein , 2000, Molecular and Cellular Biology.
[66] B. Strooper,et al. Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex , 2003, Neuron.
[67] Kazuhiro Oiwa,et al. Single‐molecule investigation of the interference between kinesin, tau and MAP2c , 2002, The EMBO journal.
[68] A. Whitworth,et al. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. , 2006, Drug discovery today.
[69] Michelle Starz-Gaiano,et al. Modeling Migration and Metastasis in Drosophila , 2007, Journal of Mammary Gland Biology and Neoplasia.
[70] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[71] Hugo J. Bellen,et al. P[acman]: A BAC Transgenic Platform for Targeted Insertion of Large DNA Fragments in D. melanogaster , 2006, Science.
[72] O. Vitolo,et al. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. , 2004, The Journal of clinical investigation.
[73] R. Cagan,et al. Drosophila models for cancer research. , 2006, Current opinion in genetics & development.
[74] F. Gao. Understanding Fragile X Syndrome Insights from Retarded Flies , 2002, Neuron.
[75] Nancy M Bonini,et al. Genome-Wide Screen for Modifiers of Ataxin-3 Neurodegeneration in Drosophila , 2007, PLoS genetics.
[76] D. Melton,et al. A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[77] Yan Wang,et al. Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.
[78] R. Nitsch,et al. Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in Transgenic Drosophila , 2004, The Journal of Neuroscience.
[79] D. Geschwind,et al. Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.
[80] Mark F Bear,et al. The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.
[81] H. Bellen,et al. Transgenesis upgrades for Drosophila melanogaster , 2007, Development.
[82] J. Olson,et al. Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration , 2007, PLoS genetics.
[83] E. Hafen,et al. Mutations Modulating Raf signaling in Drosophila eye development. , 1996, Genetics.
[84] G. Mardon,et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress , 2004, Development.
[85] James R. Woodgett,et al. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.
[86] R. Abagyan,et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. , 2007, Science.
[87] Ronald L. Davis,et al. Thirty years of olfactory learning and memory research in Drosophila melanogaster , 2005, Progress in Neurobiology.
[88] H. Shill,et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease , 2008, Neurology.
[89] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[90] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[91] Jennifer K Inlow,et al. Molecular and comparative genetics of mental retardation. , 2004, Genetics.
[92] L. Stevens,et al. Investigating the function of follicular subpopulations during Drosophila oogenesis through hormone-dependent enhancer-targeted cell ablation. , 2000, Development.
[93] J. C. Greene,et al. Immune responses , 2004 .
[94] G. Rubin,et al. Genetic transformation of Drosophila with transposable element vectors. , 1982, Science.
[95] Mark C. Fishman,et al. Pharmaceuticals: A new grammar for drug discovery , 2005, Nature.
[96] P. Sternberg,et al. let-60, a gene that specifies cell fates during C. elegans vulval induction, encodes a ras protein , 1990, Cell.
[97] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[98] Leslie Michels Thompson,et al. Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. , 2008, Human molecular genetics.
[99] C.-ting Wu,et al. Site-Specific Transformation of Drosophila via ϕC31 Integrase-Mediated Cassette Exchange , 2006, Genetics.
[100] Ann-Shyn Chiang,et al. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[101] F. Lewy. Paralysis agitans. I. Pathologische Anatomie , 1912 .
[102] H. Zoghbi,et al. Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.
[103] N. Perrimon,et al. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. , 1993, Development.
[104] R. Nussbaum,et al. FXR1, an autosomal homolog of the fragile X mental retardation gene. , 1995, The EMBO journal.
[105] Benjamin H. White,et al. A conditional tissue-specific transgene expression system using inducible GAL4 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[106] Ruben Abagyan,et al. Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease , 2007, Science.
[107] Wolfgang Wurst,et al. A Mouse for All Reasons , 2007, Cell.
[108] Daewoo Lee,et al. Selective loss of dopaminergic neurons and formation of Lewy body‐like aggregations in α‐synuclein transgenic fly neuronal cultures , 2006, The European journal of neuroscience.
[109] L. Hartwell,et al. Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.
[110] M. Kidd. Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.
[111] Joshua M. Shulman,et al. Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.
[112] Y. Rong,et al. Gene targeting by homologous recombination in Drosophila. , 2000, Science.
[113] J. Lee,et al. Rhomboid-7 and HtrA 2 / Omi act in a common pathway with the Parkinson ’ s disease factors Pink 1 and Parkin , 2022 .
[114] Gerald M. Rubin,et al. Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function , 2001, Cell.
[115] F. LaFerla,et al. Relevance of Transgenic Mouse Models to Human Alzheimer Disease* , 2009, Journal of Biological Chemistry.
[116] Norbert Perrimon,et al. Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets , 2004, PLoS biology.
[117] Paul W. Sternberg,et al. The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily , 1990, Nature.
[118] F. Tamanini,et al. Fragile X-related proteins regulate mammalian circadian behavioral rhythms. , 2008, American journal of human genetics.
[119] T. Tully,et al. A Drosophila model for Angelman syndrome , 2008, Proceedings of the National Academy of Sciences.
[120] M. Konsolaki,et al. Identification of Novel Genes That Modify Phenotypes Induced by Alzheimer's β-Amyloid Overexpression in Drosophila , 2008, Genetics.
[121] J. Trojanowski,et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. , 2002, Science.
[122] G. Rubin,et al. Transposition of cloned P elements into Drosophila germ line chromosomes. , 1982, Science.
[123] Ruben J. Cauchi,et al. The Fly as a Model for Neurodegenerative Diseases: Is It Worth the Jump? , 2007, Neurodegenerative Diseases.
[124] A. Grierson,et al. Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.
[125] Nel Roeleveld,et al. The prevalence of mental retardation: a critical review of recent literature , 1997, Developmental medicine and child neurology.
[126] M. Tranfaglia,et al. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.
[127] G. Rubin,et al. The Role of the Genome Project in Determining Gene Function: Insights from Model Organisms , 1996, Cell.
[128] J. C. Greene,et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[129] Robert W. Taylor,et al. Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. , 2007, Archives of neurology.